FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2508065431> ?p ?o ?g. }

• W2508065431 endingPage "432" @default.
• W2508065431 startingPage "425" @default.
• W2508065431 abstract "Background: The renewal capacity of neonate human cardiomyocytes provides an opportunity to manipulate endogenous cardiogenic mechanisms for supplementing the loss of cardiomyocytes caused by myocardial infarction or other cardiac diseases. GSK-3β inhibitors have been recently shown to promote cardiomyocyte proliferation in rats and mice, thus may be ideal candidates for inducing human cardiomyocyte proliferation. Methods: Human cardiomyocytes were isolated from right atrial specimens obtained during routine surgery for ventricle septal defect and cultured with either GSK-3β inhibitor (CHIR-99021) or β-catenin inhibitor (IWR-1). Immunocytochemistry was performed to visualize 5-ethynyl-2′-deoxyuridine (EdU)–positive or Ki67-positive cardiomyocytes, indicative of proliferative cardiomyocytes. Results: GSK-3β inhibitor significantly increased β-catenin accumulation in cell nucleus, whereas β-catenin inhibitor significantly reduced β-catenin accumulation in cell plasma. In parallel, GSK-3β inhibitor increased EdU-positive and Ki67-positive cardiomyocytes, whereas β-catenin inhibitor decreased EdU-positive and Ki67-positive cardiomyocytes. Conclusions: These results indicate that GSK-3β inhibitor can promote human atrial cardiomyocyte proliferation. Although it remains to be determined whether the observations in atrial myocytes could be directly applicable to ventricular myocytes, the current findings imply that Wnt/β-catenin pathway may be a valuable pathway for manipulating endogenous human heart regeneration." @default.
• W2508065431 created "2016-09-16" @default.
• W2508065431 creator A5001184585 @default.
• W2508065431 creator A5024074123 @default.
• W2508065431 creator A5050964872 @default.
• W2508065431 creator A5051405817 @default.
• W2508065431 creator A5057209908 @default.
• W2508065431 creator A5061928767 @default.
• W2508065431 creator A5077883472 @default.
• W2508065431 creator A5078455039 @default.
• W2508065431 date "2016-12-01" @default.
• W2508065431 modified "2023-10-16" @default.
• W2508065431 title "GSK-3β Inhibitor CHIR-99021 Promotes Proliferation Through Upregulating β-Catenin in Neonatal Atrial Human Cardiomyocytes" @default.
• W2508065431 cites W1787246356 @default.
• W2508065431 cites W1843219772 @default.
• W2508065431 cites W1969038150 @default.
• W2508065431 cites W1982976638 @default.
• W2508065431 cites W1998706509 @default.
• W2508065431 cites W2012191603 @default.
• W2508065431 cites W2017770112 @default.
• W2508065431 cites W2035847235 @default.
• W2508065431 cites W2037424183 @default.
• W2508065431 cites W2041597731 @default.
• W2508065431 cites W2049650832 @default.
• W2508065431 cites W2054985442 @default.
• W2508065431 cites W2059062907 @default.
• W2508065431 cites W2070515279 @default.
• W2508065431 cites W2070734183 @default.
• W2508065431 cites W2085484257 @default.
• W2508065431 cites W2086484705 @default.
• W2508065431 cites W2090353883 @default.
• W2508065431 cites W2092125592 @default.
• W2508065431 cites W2109439508 @default.
• W2508065431 cites W2120472949 @default.
• W2508065431 cites W2127112491 @default.
• W2508065431 cites W2128832316 @default.
• W2508065431 cites W2133127571 @default.
• W2508065431 cites W2135767680 @default.
• W2508065431 cites W2135978691 @default.
• W2508065431 cites W2155507705 @default.
• W2508065431 cites W2160202656 @default.
• W2508065431 cites W2162482990 @default.
• W2508065431 cites W2413274318 @default.
• W2508065431 doi "https://doi.org/10.1097/fjc.0000000000000429" @default.
• W2508065431 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27575008" @default.
• W2508065431 hasPublicationYear "2016" @default.
• W2508065431 type Work @default.
• W2508065431 sameAs 2508065431 @default.
• W2508065431 citedByCount "29" @default.
• W2508065431 countsByYear W25080654312018 @default.
• W2508065431 countsByYear W25080654312019 @default.
• W2508065431 countsByYear W25080654312020 @default.
• W2508065431 countsByYear W25080654312021 @default.
• W2508065431 countsByYear W25080654312022 @default.
• W2508065431 countsByYear W25080654312023 @default.
• W2508065431 crossrefType "journal-article" @default.
• W2508065431 hasAuthorship W2508065431A5001184585 @default.
• W2508065431 hasAuthorship W2508065431A5024074123 @default.
• W2508065431 hasAuthorship W2508065431A5050964872 @default.
• W2508065431 hasAuthorship W2508065431A5051405817 @default.
• W2508065431 hasAuthorship W2508065431A5057209908 @default.
• W2508065431 hasAuthorship W2508065431A5061928767 @default.
• W2508065431 hasAuthorship W2508065431A5077883472 @default.
• W2508065431 hasAuthorship W2508065431A5078455039 @default.
• W2508065431 hasConcept C126322002 @default.
• W2508065431 hasConcept C134018914 @default.
• W2508065431 hasConcept C137620995 @default.
• W2508065431 hasConcept C16613235 @default.
• W2508065431 hasConcept C182996813 @default.
• W2508065431 hasConcept C207200792 @default.
• W2508065431 hasConcept C2778921608 @default.
• W2508065431 hasConcept C2779324961 @default.
• W2508065431 hasConcept C30145163 @default.
• W2508065431 hasConcept C35866371 @default.
• W2508065431 hasConcept C55493867 @default.
• W2508065431 hasConcept C62112901 @default.
• W2508065431 hasConcept C62478195 @default.
• W2508065431 hasConcept C71924100 @default.
• W2508065431 hasConcept C86803240 @default.
• W2508065431 hasConcept C95444343 @default.
• W2508065431 hasConceptScore W2508065431C126322002 @default.
• W2508065431 hasConceptScore W2508065431C134018914 @default.
• W2508065431 hasConceptScore W2508065431C137620995 @default.
• W2508065431 hasConceptScore W2508065431C16613235 @default.
• W2508065431 hasConceptScore W2508065431C182996813 @default.
• W2508065431 hasConceptScore W2508065431C207200792 @default.
• W2508065431 hasConceptScore W2508065431C2778921608 @default.
• W2508065431 hasConceptScore W2508065431C2779324961 @default.
• W2508065431 hasConceptScore W2508065431C30145163 @default.
• W2508065431 hasConceptScore W2508065431C35866371 @default.
• W2508065431 hasConceptScore W2508065431C55493867 @default.
• W2508065431 hasConceptScore W2508065431C62112901 @default.
• W2508065431 hasConceptScore W2508065431C62478195 @default.
• W2508065431 hasConceptScore W2508065431C71924100 @default.
• W2508065431 hasConceptScore W2508065431C86803240 @default.
• W2508065431 hasConceptScore W2508065431C95444343 @default.
• W2508065431 hasIssue "6" @default.
• W2508065431 hasLocation W25080654311 @default.

• next